21 décembre 2009
14:45 E.S.T.

Generation of redesigned homing endonucleases comprising DNA-binding domains derived from two different scaffolds

Grizot S, Epinat JC, Thomas S, Duclert A, Rolland S, Pâques F, Duchateau P.
Nucleic Acids Res. 2010 Apr;38(6):2006-18. doi: 10.1093/nar/gkp1171. Epub 2009 Dec 21.

Lire le communiqué

21 octobre 2009
19:00 E.S.T.

Reduced immunoglobulin class switch recombination in the absence of Artemis

Rivera-Munoz P, Soulas-Sprauel P, Le Guyader G, Abramowski V, Bruneau S, Fischer A, Pâques F, de Villartay JP.
Blood, 22 October 2009, Vol. 114, No. 17, pp. 3601-3609.

Lire le communiqué

08 octobre 2009
19:00 E.S.T.

Targeted gene modifications in drug discovery and development

Cabaniols JP, Mathis L, Delenda C.
Curr Opin Pharmacol. 2009 October; 9(5):657-63.

Lire le communiqué

18 août 2009
09:59 E.S.T.

Targeted approaches for gene therapy and the emergence of engineered meganucleases

Galetto R, Duchateau P, Pâques F.
Expert Opinion on Biological Therapy, October 2009, Vol. 9, No. 10, Pages 1289-1303

Lire le communiqué

06 juillet 2009
19:00 E.S.T.

Efficient targeting of a SCID gene by an engineered single-chain homing endonuclease

Grizot S, Smith J, Daboussi F, Prieto J, Redondo P, Merino N, Villate M , Thomas S, Lemaire L, Montoya G, Blanco FJ, Pâques F, Duchateau P.
Nucleic Acids Research, Volume 37, Issue16, 5405-5419

Lire le communiqué

Publications scientifiques

Generation of redesigned homing endonucleases comprising DNA-binding domains derived from two different scaffolds

Reduced immunoglobulin class switch recombination in the absence of Artemis

Targeted gene modifications in drug discovery and development

Targeted approaches for gene therapy and the emergence of engineered meganucleases

Efficient targeting of a SCID gene by an engineered single-chain homing endonuclease